A Study Evaluating Safety and Efficacy of Venetoclax in Combination With Azacitidine Versus Standard of Care After Allogeneic Stem Cell Transplantation (SCT) in Participants With Acute Myeloid Leukemia (AML)
PHASE3
The main objective of this study is to evaluate the efficacy of venetoclax ...
Status
Terminated
Location
Arizona Oncology - Scottsdale - Cancer Transplant Institute /ID# 239711
Safety Study of Oral Azacitidine (CC-486) as Maintenance Therapy After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in Participants With Acute Myeloid Leukemia (AML) or Myelodysplastic Syndromes (MDS).
PHASE1
The purpose of the study is to determine the maximal tolerated dose and sch...
A Study of Cusatuzumab Plus Azacitidine in Japanese Participants With Newly Diagnosed Acute Myeloid Leukemia or High-risk Myelodysplastic Syndrome Who Are Not Candidates for Intensive Treatment
PHASE1
The purpose of this study is to determine the recommended Phase 2 dose and ...